According to Foresight News, the decentralized research (DeSci) platform Bio Protocol will launch its first BioAgent sales project Aubrai. Aubrai has a total supply of 2 million tokens, with 20% allocated for sales, 6% for liquidity pool, 15% for treasury, 20.1% for initial funders, 10% for LEVF, 22% for VitaDAO, and 6.9% for Bio Protocol. The token generation event (TGE) will take place on August 25.
Aubrai is a decentralized science intelligence agent jointly developed by VitaDAO and BIO, aimed at combating human aging.
